This treatment reduced the expression of NLRP3, caspase-1, and IL-1β, and the occurrence of cell pyroptosis and inflammatory response, suggesting that the protective effect of EA on cerebral ischemia/reperfusion injury may be played by inhibiting the pyroptosis pathway dependent on caspase-1. The gene discussed is CASP1; the disease is brain ischemia.